Doctors at Banner North Colorado Medical Center are using artificial intelligence to get a head start diagnosing detect lung cancer.
A cancerous tumor is not a single enemy. It is made up of many different cell populations that can behave in very different ways.
Lung cancer remains the leading cause of cancer deaths in the United States, and older adults are at higher risk. But only ...
Medical Radiology Manipulator Ludovic Foy prepares a woman before she has a lung scan for the Acapulco experimentation in Ajaccio on December 16, 2021 on the French Mediterranean island of Corsica. - ...
You will be redirected to our submission process. Liquid biopsy has rapidly transformed thoracic oncology, moving from a baseline molecular profiling tool to a dynamic approach for longitudinal ...
SAN ANTONIO — A robotic-assisted procedure is helping doctors get a closer look inside the lungs and diagnose lung cancer earlier and more accurately. At Methodist Hospital Metropolitan, Dr. AJ ...
Lung cancer is the leading cause of cancer death in American women — and a growing share of new cases are in women who've never smoked. Former YouTube CEO Susan Wojcicki was one of those women. A ...
An unexpected study found that young non-smokers with healthier diets had higher rates of lung cancer, raising questions about whether pesticide exposure from conventionally grown produce could play a ...
A personal injury attorney is raising questions about the Albany fuel pump explosions, the warning signs missed, and who could be held responsible. Sports artist documents history through unique ...
A new program aims to improve early detection of lung cancer in Illinois, according to a community announcement. The Amy Keil Schmidt Early Lung Cancer Detection Program will expand access to ...
Scientists have identified proteins that could signal increased lung cancer risk, as well as a drug that could reduce the odds of a tumor developing. By Nina Agrawal See more of our coverage in your ...
At least 12 of my colleagues boarded planes to the American Society of Clinical Oncology conference in Chicago last week to hear Charles Swanton of the Francis Crick Institute in London share results ...